Mon, 03 Dec 2018 13:58:05 GMT
GSK to acquire cancer drugmaker Tesaro in $5.1B deal
GlaxoSmithKline agreed on a deal to acquire the US cancer drugmaker Tesaro for $5.1B, the major biotech investment made by the drug specialist, as it hopes to reform its pharmaceuticals portfolio.